WindRose Health Investors has closed its fifth fund, WindRose Health Investors V LP, with $705 million of capital commitments. The new fund was oversubscribed and closed at its hard cap.
WindRose was formerly known as MTS Health Investors but rebranded in February 2018. The firm shares a common lineage with healthcare investment bank MTS Health Partners but the two businesses are independent and have operated separately for many years.
The senior investment team at WindRose has been investing together for well over a decade and has over 80 years of combined experience working with healthcare businesses. “WindRose’s deep domain knowledge and extensive network of healthcare industry relationships equips us to identify attractive investment targets and to bring new growth opportunities to each of the companies with which we partner,” said Curtis Lane, the firm’s founding partner.
WindRose makes equity investments in US-based companies with enterprise valuations of $25 million to $300 million that operate within the services sectors of the healthcare industry. Typical transaction structures include buyouts, recapitalizations, corporate carve-outs and growth equity investments. The firm is based in New York (www.windrose.com).
“It is gratifying to see our team’s strategy and track record so well received in the market. We are grateful for the trust placed in us by a distinguished group of investors and will work diligently to execute our plan,” said Oliver Moses, managing partner at WindRose.
With the closing of the fifth fund, WindRose now manages over $1.4 billion of capital.
© 2019 Private Equity Professional | January 7, 2019